NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

ADALTA LIMITED (1AD)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of 1AD: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Registry Pty Ltd
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000001AD2
Address: Room 204, LIMS2 La Trobe Institute for Molecular Science, Science Drive, La Trobe University, VIC 3086
Tel:  +61 3 9479 5159

Date first listed: 22/08/2016

Sector: Pharmaceuticals & Biotechnology 

News & Events

Expand this box to read and print

The suspension of trading in the securities of Adalta Limited will be lifted immediately following the release by 1AD of an announcement regarding a capital raising.

15/12/2021

The company releases its Cash Position and Corporate Presentation.

15/12/2021

AdAlta has secured commitments to raise A$3.75m via an institutional placement supported by multiple institutional investors. AdAlta to initiate an Entitlement Offer for eligible shareholders of AdAlta on the same terms to raise up to a further A$2.2m. Funds raised together with existing cash reserves support progressing key development milestones in 2022 for both lead program AD-214 and partnered programs.

15/12/2021

The company releases a notice of proposed issue of securities.

15/12/2021

The securities of Adalta Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of 1AD, pending the release of an announcement regarding a capital raising.

14/12/2021

listed entity carried for record purposes only

22/08/2016

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    06/09/2024Tim Oldham100,000$0.022$2,195
    26/10/2021Tim Oldham235,000$0.085$19,992
    26/11/2020Tim Oldham61,000$0.120$7,320
    21/09/2016James Williams40,000$0.230$9,200

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Paul MacLemanExecutive Chairman18/04/2015
    Tim OldhamManaging Director, CEO14/10/2019
    Dallas HartmanCOO09/10/2017
    Cameron JonesCFO, Company Secretary31/05/2017
    David FullerNon Exec Director22/07/2020
    Iain RossNon Exec Director20/11/2024
    Michelle BurkeNon Exec Director20/11/2024

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Robert PeachNon Exec Director14/11/201620/11/2024
    Liddy McCallNon Exec Director18/10/201024/03/2023
    James WilliamsAlternate Director18/10/201024/03/2023
    Rosalind WilsonNon Exec Director01/08/201927/03/2020
    John ChiplinNon Exec Director05/03/201403/01/2020
    Sam CobbManaging Director, CEO30/08/200712/08/2019

    Date of first appointment, title may have changed.